MYADM antibody (AA 51-150) (FITC)

Catalog No. ABIN6944186

This anti-MYADM antibody is a Rabbit Polyclonal antibody detecting MYADM in WB, IF (cc) and IF (p). Suitable for Human.

Quick Overview for MYADM antibody (AA 51-150) (FITC) (ABIN6944186)

Target: MYADM (Myeloid-Associated Differentiation Marker (MYADM))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This MYADM antibody is conjugated to FITC

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Product Details anti-MYADM Antibody (FITC)

Binding Specificity: AA 51-150

Specificity: This antibody's immunogen sequence has 91 % homology (10/11 residues) with the Rat MYADM protein and is predicted to work with Rat samples

Cross-Reactivity: Human

Predicted Reactivity: Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human MYADM

Isotype: IgG

Application Details

Application Notes: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for MYADM

Target: MYADM (Myeloid-Associated Differentiation Marker (MYADM))

Alternative Name: MYADM

Background:

Synonyms: MYADM, MYADM_HUMAN, myeloid associated differentiation marker, Myeloid upregulated protein, Myeloid-associated differentiation marker, Protein SB135.

Background: Myeloid-associated differentiation marker (MYADM) is a member of the MAL family with the unique features of having eight transmembrane regions and a ubiquitous pattern of expression and of being found localized at the plasma membrane. MYADM has been found to be associated with the differentiation of hematopoietic cells or acute promyelocytic leukemia cells. MYADM could serve as a new marker for hematopoietic differentiation and is a target for diagnostic, prognostic and/or therapeutic interventions.

Gene ID: 91663

UniProt: Q96S97